Chapter/Section Purchase

1 mRNA Vaccines & Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 mRNA Vaccines & Therapeutics Segment by Type
1.2.1 Global mRNA Vaccines & Therapeutics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 mRNA Vaccines & Therapeutics Segment by Application
1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application: (2021-2027)
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Global mRNA Vaccines & Therapeutics Market Size Estimates and Forecasts
1.4.1 Global mRNA Vaccines & Therapeutics Revenue 2016-2027
1.4.2 Global mRNA Vaccines & Therapeutics Sales 2016-2027
1.4.3 mRNA Vaccines & Therapeutics Market Size by Region: 2016 Versus 2021 Versus 2027

2 mRNA Vaccines & Therapeutics Market Competition by Manufacturers
2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2016-2021)
2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers mRNA Vaccines & Therapeutics Manufacturing Sites, Area Served, Product Type
2.5 mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
2.5.1 mRNA Vaccines & Therapeutics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest mRNA Vaccines & Therapeutics Players Market Share by Revenue
2.5.3 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region
3.1 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.3.1 North America mRNA Vaccines & Therapeutics Sales by Country
3.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.4.1 Europe mRNA Vaccines & Therapeutics Sales by Country
3.4.2 Europe mRNA Vaccines & Therapeutics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific mRNA Vaccines & Therapeutics Market Facts & Figures by Region
3.5.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region
3.5.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.6.1 Latin America mRNA Vaccines & Therapeutics Sales by Country
3.6.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.7.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country
3.7.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global mRNA Vaccines & Therapeutics Historic Market Analysis by Type
4.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021)
4.3 Global mRNA Vaccines & Therapeutics Price by Type (2016-2021)

5 Global mRNA Vaccines & Therapeutics Historic Market Analysis by Application
5.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
5.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2021)
5.3 Global mRNA Vaccines & Therapeutics Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Moderna Therapeutics
6.1.1 Moderna Therapeutics Corporation Information
6.1.2 Moderna Therapeutics Description and Business Overview
6.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.1.5 Moderna Therapeutics Recent Developments/Updates
6.2 CureVac
6.2.1 CureVac Corporation Information
6.2.2 CureVac Description and Business Overview
6.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
6.2.5 CureVac Recent Developments/Updates
6.3 Translate Bio
6.3.1 Translate Bio Corporation Information
6.3.2 Translate Bio Description and Business Overview
6.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
6.3.5 Translate Bio Recent Developments/Updates
6.4 BioNTech
6.4.1 BioNTech Corporation Information
6.4.2 BioNTech Description and Business Overview
6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
6.4.5 BioNTech Recent Developments/Updates
6.5 Sangamo Therapeutics
6.5.1 Sangamo Therapeutics Corporation Information
6.5.2 Sangamo Therapeutics Description and Business Overview
6.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.5.5 Sangamo Therapeutics Recent Developments/Updates
6.6 Argos Therapeutics
6.6.1 Argos Therapeutics Corporation Information
6.6.2 Argos Therapeutics Description and Business Overview
6.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.6.5 Argos Therapeutics Recent Developments/Updates
6.7 In-Cell-Art
6.6.1 In-Cell-Art Corporation Information
6.6.2 In-Cell-Art Description and Business Overview
6.6.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
6.7.5 In-Cell-Art Recent Developments/Updates
6.8 eTheRNA
6.8.1 eTheRNA Corporation Information
6.8.2 eTheRNA Description and Business Overview
6.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
6.8.5 eTheRNA Recent Developments/Updates
6.9 Ethris
6.9.1 Ethris Corporation Information
6.9.2 Ethris Description and Business Overview
6.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
6.9.5 Ethris Recent Developments/Updates
6.10 Tiba Biotechnology
6.10.1 Tiba Biotechnology Corporation Information
6.10.2 Tiba Biotechnology Description and Business Overview
6.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
6.10.5 Tiba Biotechnology Recent Developments/Updates

7 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
7.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
7.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 mRNA Vaccines & Therapeutics Distributors List
8.3 mRNA Vaccines & Therapeutics Customers

9 mRNA Vaccines & Therapeutics Market Dynamics
9.1 mRNA Vaccines & Therapeutics Industry Trends
9.2 mRNA Vaccines & Therapeutics Growth Drivers
9.3 mRNA Vaccines & Therapeutics Market Challenges
9.4 mRNA Vaccines & Therapeutics Market Restraints

10 Global Market Forecast
10.1 mRNA Vaccines & Therapeutics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Type (2022-2027)
10.2 mRNA Vaccines & Therapeutics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Application (2022-2027)
10.3 mRNA Vaccines & Therapeutics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer